Given's PillCam gets Italian reimbursement boost:
This article was originally published in Clinica
Executive Summary
Given Imaging has secured wider access for its PillCam endoscopy "video pill" in Europe, with the approval of its reimbursement in Italy's Piedmont region. The decision supports the use of the technology - until recently known as M2A - as an outpatient procedure in the treatment of a number of small bowel disorders, including Crohn's disease, coeliac disease, lymphoma, polyposis and occult bleeding. The Yoqneam, Israel-based specialist in capsule endoscopy claims that the approval by the regional government of Piedmont, with 4.3 million people, extends PillCam's reimbursement coverage to an EU-wide population of around 44 million. Given Imaging rebranded the M2A video capsule as PillCam on September 9 (see Clinica No 1124, p 17).